MHRA review leads slimmer profits at Calea

Home healthcare and pharmaceuticals business Calea UK has reported a 5.2% increase in turnover to £88.8m for the year ended 31 December 2019 on the back of continued increases in patient numbers. However, the company, which is owned by German healthcare giant Fresenius, said an inspection by the MHRA during the year had identified a…

You must be a HM Subscriber to view this content.

Subscribe Now »